What is the Inovio Pharmaceuticals Inc (INO) price today?

The price of Inovio Pharmaceuticals Inc (INO) today is $1.14. This value reflects the latest market rate available on Pluang. Check the asset page for additional details such as 24-hour change, market trends, and trading volume.

What are the trading hours of US Stocks?

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.

Do I get a dividend from investing in US Stocks?

Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.

What is the fee for each transaction?

Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Trade on Pluang

One platform for all markets

Download

Investment

Features

Fees Safety

Academy

Pluang+

Home/Explore/US Market Price/Stocks/INO

Buy & Sell Inovio Pharmaceuticals Inc (INO) – Inovio Pharmaceuticals Inc Price Today

Overview Financials Technicals Analysis Corp Action About

24H

YTD

Aura AI Summary

INO's stock trades at $1.135, down 4.62% on the day, amid a bearish technical signal and significant negative financials, including a -130% net income margin and declining revenue. The company has consistently beaten quarterly EPS expectations, but faces a major class action lawsuit with a recent filing deadline, dominating recent news flow. Analyst coverage shows a slight majority 'Buy' rating at 52.95%, though cash flow trends remain volatile with heavy operating losses.

The outlook is highly speculative, presenting a high-risk opportunity contingent on a successful turnaround of its core biotechnology business. Key risks include the ongoing securities litigation, persistent cash burn, and the challenge of translating clinical progress into sustainable revenue. The stock's future hinges on business execution and resolving legal overhangs.

Read full analysis

Key Stats

Market Cap
$92.20M
Sector
Health
3M Drawdown
-44.44%
Enterprise Value
$43.05M
Dividend Yield
-
Trading Activity
100% Buy | 0% Sell
Typical Hold Time
41 days

$1.14

52W Low: $1.05

07 Apr 2026

52W High: $2.87

08 Sep 2025

Inovio Pharmaceuticals Inc (INO) is currently valued at a market capitalization of $92.20M, with an enterprise value of $43.05M. Over the past 52 weeks, Inovio Pharmaceuticals Inc has traded between a low of $1.05 and a high of $2.87, highlighting its annual price range. Over the past three months, Inovio Pharmaceuticals Inc has recorded a drawdown of -44.44%, reflecting recent price volatility. On average, investors hold Inovio Pharmaceuticals Inc for approximately 41 days, indicating typical investor behavior on the platform.

About Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Technical Indicators

Overall Summary

Bearish (6)Neutral (10)Bullish (11)

News

Globe Newswire17 day ago

INO FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Inovio Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securities Class Action – INO

Globe Newswire19 day ago

Deadline Alert: Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

Globe Newswire20 day ago

INO FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Inovio Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securities Class Action – INO

Globe Newswire20 day ago

ROSEN, THE FIRST FILING FIRM, Encourages Trip.com Group Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - TCOM

Globe Newswire23 day ago

ROSEN, THE FIRST FILING FIRM, Encourages Kyndryl Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – KD

People also bought

US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

Market Cap
$92.20M
Sector
Health
3M Drawdown
-44.44%
Enterprise Value
$43.05M
Dividend Yield
-
Trading Activity
100% Buy | 0% Sell
Typical Hold Time
41 days

$1.14

52W Low: $1.05

07 Apr 2026

52W High: $2.87

08 Sep 2025

Let’s invest in this asset by signing up or download!

Buy & Sell Inovio Pharmaceuticals Inc (INO) – Inovio Pharmaceuticals Inc Price Today

Aura AI Summary

Key Stats

About Inovio Pharmaceuticals Inc

People also bought

Key Stats

Invest

Features

Fees

Learn

Investment Clubs (Coming Soon)

Support

iOS App Store

Google Play Store